The billionaire entrepreneur and CEO of IT services company World Wide Technology remains bullish about the future of AI.

Shares of Moderna Inc. MRNA slipped 3.43% to $65.69 Friday, on what proved to be an all-around mixed trading session for the ...

RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $75.00. The ...

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

With the flu season imminent, new COVID-19 and influenza vaccines are available. What’s new with the vaccines and when should ...

Plus, we'll look at the how gas prices can affect elections and do the numbers on the new COVID vaccine in this week's ...

Pfizer’s return policy is similar to policies from other drugmakers for pediatric flu vaccines, also recommended during the ...

The study investigates COVID-19 vaccine-related myocarditis in adolescents, revealing clinical characteristics and risks of ...

Wall Street remains steady as economic reports align with expectations, with the S&P 500 inching up 0.1% in afternoon trading ...

International Emmys nominations are out, and three countries will battle for both the marquee Drama Series and Comedy Series prizes. Here the full list.

Shares of Moderna Inc. MRNA slipped 2.63% to $68.02 Thursday, on what proved to be an all-around favorable trading session ...